Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Behzad Etemad

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
AIDS (London, England)|November 21, 2015
The size of the expressed HIV reservoir predicts timing of viral rebound after treatment interruptionJonathan Z Li, Behzad Etemad, Hayat Ahmed, et al.
Ebiomedicine|July 19, 2016
Humoral Immune Pressure Selects for HIV-1 CXC-chemokine Receptor 4-using VariantsNina Lin, Oscar A Gonzalez, Ludy Registre, et al.
The Journal of Infectious Diseases|January 13, 2022
SARS-CoV-2 Placentitis Associated With B.1.617.2 (Delta) Variant and Fetal Distress or DemiseLydia L Shook, Sara Brigida, James Regan, et al.
Science Translational Medicine|May 10, 2023
Autologous neutralizing antibodies increase with early antiretroviral therapy and shape HIV rebound after treatment interruptionElmira Esmaeilzadeh, Behzad Etemad, Christy L Lavine, et al.
Retrovirology|December 28, 2013
HIV-1 envelope replication and α4β7 utilization among newly infected subjects and their corresponding heterosexual partnersVictor Pena-Cruz, Behzad Etemad, Nikolaos Chatziandreou, et al.
Pathogens & Immunity|January 16, 2018
Impact of HLA Class I Alleles on Timing of HIV Rebound After Antiretroviral Treatment InterruptionYou Jeong Park, Behzad Etemad, Hayat Ahmed, et al.
Lab on a Chip|July 14, 2017
Rapid, label-free CD4 testing using a smartphone compatible deviceManoj Kumar Kanakasabapathy, Hardik J Pandya, Mohamed Shehata Draz, et al.
Journal of Virology|December 21, 2022
Transcriptomic Signatures of Human Immunodeficiency Virus Post-Treatment ControlAdam Wedrychowski, Holly Anne Martin, Yijia Li, et al.
Science Translational Medicine|April 22, 2026
Expansion of stemlike HIV-specific CD8<sup>+</sup> T cells and limited viral epitope diversity characterize durable posttreatment control of HIVCharles R Crain, Aljawharah Alrubayyi, Itai Muzhingi, et al.
Biorxiv : the Preprint Server for Biology|September 15, 2025
A New Type of Nonsuppressible Viremia Produced by HIV-Infected MacrophageMatthew J Moeser, Olivia D Council, Nathan Long, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
AIDS (London, England)|November 21, 2015
The size of the expressed HIV reservoir predicts timing of viral rebound after treatment interruptionJonathan Z Li, Behzad Etemad, Hayat Ahmed, et al.
Ebiomedicine|July 19, 2016
Humoral Immune Pressure Selects for HIV-1 CXC-chemokine Receptor 4-using VariantsNina Lin, Oscar A Gonzalez, Ludy Registre, et al.
The Journal of Infectious Diseases|January 13, 2022
SARS-CoV-2 Placentitis Associated With B.1.617.2 (Delta) Variant and Fetal Distress or DemiseLydia L Shook, Sara Brigida, James Regan, et al.
Science Translational Medicine|May 10, 2023
Autologous neutralizing antibodies increase with early antiretroviral therapy and shape HIV rebound after treatment interruptionElmira Esmaeilzadeh, Behzad Etemad, Christy L Lavine, et al.
Retrovirology|December 28, 2013
HIV-1 envelope replication and α4β7 utilization among newly infected subjects and their corresponding heterosexual partnersVictor Pena-Cruz, Behzad Etemad, Nikolaos Chatziandreou, et al.
Pathogens & Immunity|January 16, 2018
Impact of HLA Class I Alleles on Timing of HIV Rebound After Antiretroviral Treatment InterruptionYou Jeong Park, Behzad Etemad, Hayat Ahmed, et al.
Lab on a Chip|July 14, 2017
Rapid, label-free CD4 testing using a smartphone compatible deviceManoj Kumar Kanakasabapathy, Hardik J Pandya, Mohamed Shehata Draz, et al.
Journal of Virology|December 21, 2022
Transcriptomic Signatures of Human Immunodeficiency Virus Post-Treatment ControlAdam Wedrychowski, Holly Anne Martin, Yijia Li, et al.
Science Translational Medicine|April 22, 2026
Expansion of stemlike HIV-specific CD8<sup>+</sup> T cells and limited viral epitope diversity characterize durable posttreatment control of HIVCharles R Crain, Aljawharah Alrubayyi, Itai Muzhingi, et al.
Biorxiv : the Preprint Server for Biology|September 15, 2025
A New Type of Nonsuppressible Viremia Produced by HIV-Infected MacrophageMatthew J Moeser, Olivia D Council, Nathan Long, et al.
Pageof 3